These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23565574)

  • 1. Applicability of a blood-brain barrier specific artificial membrane permeability assay at the early stage of natural product-based CNS drug discovery.
    Könczöl A; Müller J; Földes E; Béni Z; Végh K; Kéry A; Balogh GT
    J Nat Prod; 2013 Apr; 76(4):655-63. PubMed ID: 23565574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid screening of brain-penetrable antioxidants from natural products by blood-brain barrier specific permeability assay combined with DPPH recognition.
    Zhu J; Yi X; Zhang J; Chen S; Wu Y
    J Pharm Biomed Anal; 2018 Mar; 151():42-48. PubMed ID: 29304411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three newly identified lipophilic flavonoids in Tanacetum parthenium supercritical fluid extract penetrating the Blood-Brain Barrier.
    Végh K; Riethmüller E; Hosszú L; Darcsi A; Müller J; Alberti Á; Tóth A; Béni S; Könczöl Á; Balogh GT; Kéry Á
    J Pharm Biomed Anal; 2018 Feb; 149():488-493. PubMed ID: 29182998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the Passive Intestinal Absorption of Medicinal Plant Extract Constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA).
    Petit C; Bujard A; Skalicka-Woźniak K; Cretton S; Houriet J; Christen P; Carrupt PA; Wolfender JL
    Planta Med; 2016 Mar; 82(5):424-31. PubMed ID: 26872320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB.
    Di L; Kerns EH; Bezar IF; Petusky SL; Huang Y
    J Pharm Sci; 2009 Jun; 98(6):1980-91. PubMed ID: 18837012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
    Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
    Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in brain penetration evaluation in drug discovery and development.
    Liu X; Chen C; Smith BJ
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiologically based modeling strategy during preclinical CNS drug development.
    Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
    Mol Pharm; 2014 Mar; 11(3):836-48. PubMed ID: 24446829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery.
    Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R
    Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.
    Radan M; Djikic T; Obradovic D; Nikolic K
    Eur J Pharm Sci; 2022 Jan; 168():106056. PubMed ID: 34740787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation.
    Zhang X; Liu T; Fan X; Ai N
    J Mol Graph Model; 2017 Aug; 75():347-354. PubMed ID: 28628860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.
    de Lange EC; Hammarlund-Udenaes M
    Clin Pharmacol Ther; 2015 Apr; 97(4):380-94. PubMed ID: 25670219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput artificial membrane permeability assay for blood-brain barrier.
    Di L; Kerns EH; Fan K; McConnell OJ; Carter GT
    Eur J Med Chem; 2003 Mar; 38(3):223-32. PubMed ID: 12667689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.
    Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A
    Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates.
    Adenot M; Lahana R
    J Chem Inf Comput Sci; 2004; 44(1):239-48. PubMed ID: 14741033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin-PAMPA: a new method for fast prediction of skin penetration.
    Sinkó B; Garrigues TM; Balogh GT; Nagy ZK; Tsinman O; Avdeef A; Takács-Novák K
    Eur J Pharm Sci; 2012 Apr; 45(5):698-707. PubMed ID: 22326705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.